Linked Life Data

20558922

Source:http://linkedlifedata.com/resource/pubmed/id/20558922

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-6-18
pubmed:abstractText
The incidence of the gastrointestinal adverse effects is important to determine as these effects are the reason for lower compliance of alpha-glucosidase inhibitors (alphaGIs). There has been no direct investigation of the adverse effects with acarbose or miglitol, therefore we compared them in healthy subjects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1349-7235
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1085-7
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study.
pubmed:affiliation
Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama.
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't